These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


245 related items for PubMed ID: 1706399

  • 1. Complement-mediated lysis of Trypanosoma cruzi trypomastigotes by human anti-alpha-galactosyl antibodies.
    Almeida IC, Milani SR, Gorin PA, Travassos LR.
    J Immunol; 1991 Apr 01; 146(7):2394-400. PubMed ID: 1706399
    [Abstract] [Full Text] [Related]

  • 2. Anti-alpha-galactosyl antibodies in chagasic patients. Possible biological significance.
    Milani SR, Travassos LR.
    Braz J Med Biol Res; 1988 Apr 01; 21(6):1275-86. PubMed ID: 2471563
    [Abstract] [Full Text] [Related]

  • 3. [Levels of anti-Gal antibodies in persons infected and non-infected with Trypanosoma cruzi. Probably induced by bacteria and by the parasite].
    González J, Ramírez C, Seguel X, Gutiérrez B, Manque P, Porcile P, Neira I, Sagua H.
    Bol Chil Parasitol; 1995 Apr 01; 50(1-2):3-9. PubMed ID: 8573266
    [Abstract] [Full Text] [Related]

  • 4. Molecular mimicry between Trypanosoma cruzi and host nervous tissues.
    Avila JL.
    Acta Cient Venez; 1992 Apr 01; 43(6):330-40. PubMed ID: 1343745
    [Abstract] [Full Text] [Related]

  • 5. Reactivity of chagasic antigal antibodies with noninfected cells treated with Trypanosoma cruzi secreted/excreted antigens.
    Yokoyama-Yasunaka JK, Piazza RM, Umezawa ES, Stolf AM.
    J Clin Lab Anal; 1998 Apr 01; 12(2):108-14. PubMed ID: 9524295
    [Abstract] [Full Text] [Related]

  • 6. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
    Umezawa ES, Shikanai-Yasuda MA, Stolf AM.
    J Clin Lab Anal; 1996 Apr 01; 10(6):407-13. PubMed ID: 8951611
    [Abstract] [Full Text] [Related]

  • 7. GPI-anchored glycoconjugates from Trypanosoma cruzi trypomastigotes are recognized by lytic anti-alpha-galactosyl antibodies isolated from patients with chronic Chagas' disease.
    Almeida IC, Ferguson MA, Schenkman S, Travassos LR.
    Braz J Med Biol Res; 1994 Feb 01; 27(2):443-7. PubMed ID: 8081263
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lack of cross-reactivity of lytic antibodies with bloodstream forms of Trypanosoma cruzi zymodemes generated in a mouse experimental model.
    Wallace A, Sanchez G, Venegas J, Solari A.
    Exp Parasitol; 1995 Mar 01; 80(2):176-85. PubMed ID: 7895829
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Glycoconjugates of Trypanosoma cruzi: a 74 kD antigen of trypomastigotes specifically reacts with lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas disease.
    Almeida IC, Krautz GM, Krettli AU, Travassos LR.
    J Clin Lab Anal; 1993 Mar 01; 7(6):307-16. PubMed ID: 8277354
    [Abstract] [Full Text] [Related]

  • 12. Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement-mediated lysis.
    Krettli AU, Weisz-Carrington P, Nussenzweig RS.
    Clin Exp Immunol; 1979 Sep 01; 37(3):416-23. PubMed ID: 116784
    [Abstract] [Full Text] [Related]

  • 13. Immunogenic Gal alpha 1----3Gal carbohydrate epitopes are present on pathogenic American Trypanosoma and Leishmania.
    Avila JL, Rojas M, Galili U.
    J Immunol; 1989 Apr 15; 142(8):2828-34. PubMed ID: 2467941
    [Abstract] [Full Text] [Related]

  • 14. Antibody to Trypanosoma cruzi neuraminidase enhances infection in vitro and identifies a subpopulation of trypomastigotes.
    Cavallesco R, Pereira ME.
    J Immunol; 1988 Jan 15; 140(2):617-25. PubMed ID: 3121750
    [Abstract] [Full Text] [Related]

  • 15. Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: dependence on the developmentally regulated synthesis of surface protein and N-linked carbohydrate.
    Sher A, Hieny S, Joiner K.
    J Immunol; 1986 Nov 01; 137(9):2961-7. PubMed ID: 3531342
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of trypomastigotes' infectivity by a monoclonal antibody directed to a glycoconjugated fraction of epimastigotes of Trypanosoma cruzi.
    Imaz MS, Esteva M, Velázquez E, Ruiz AM, Segura EL, Marcipar AJ.
    Rev Latinoam Microbiol; 1997 Nov 01; 39(1-2):33-46. PubMed ID: 10932713
    [Abstract] [Full Text] [Related]

  • 17. Resistance against Trypanosoma cruzi associated to anti-living trypomastigote antibodies.
    Krettli AU, Brener Z.
    J Immunol; 1982 May 01; 128(5):2009-12. PubMed ID: 6801127
    [Abstract] [Full Text] [Related]

  • 18. Polyclonal B-cell activation by Neisseria meningitidis capsular polysaccharides elicit antibodies protective against Trypanosoma cruzi infection in vitro.
    Oliveira TG, Milani SR, Travassos LR.
    J Clin Lab Anal; 1996 May 01; 10(4):220-8. PubMed ID: 8811466
    [Abstract] [Full Text] [Related]

  • 19. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M, de Titto E.
    Acta Physiol Pharmacol Latinoam; 1985 May 01; 35(1):1-47. PubMed ID: 2932884
    [Abstract] [Full Text] [Related]

  • 20. Antibody-independent, natural resistance of birds to Trypanosoma cruzi infection.
    Kierszenbaum F, Gottlieb CA, Budzko DB.
    J Parasitol; 1981 Oct 01; 67(5):656-60. PubMed ID: 6795329
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.